Skip to main content
 This program is not active.
Not Found
Digital Seminar

GERD, Dyspepsia and Barrett’s Esophagus: Treatment Updates for 2025


Speaker:
Peter Buch, MD, AGAF, FACP
Copyright:
May 15, 2025
Product Code:
POS078942
Media Type:
Digital Seminar


Description

Please join Dr. Peter Burch, a double certified clinical gastroenterologist with over 30 years of specialty experience, to explore GERD in a practical, case based, and interaction session. He will provide the highlights on alarm signs with GERD, medical mimickers of GERD, making the correct diagnosis of GERD, clinical differences between PPIs, and discussion on Vonoprazan as a PPI alternative.

At the conclusion of the training, you will have the necessary clinical updates and tools to confidently manage patient with GERD, dyspepsia, and Barrett’s esophagus.

Credit

Planning Committee Disclosure - No relevant relationships

All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners.  For speaker disclosures, please see the faculty biography.




Speaker

Peter Buch, MD, AGAF, FACP's Profile

Peter Buch, MD, AGAF, FACP Related seminars and products


Peter Buch, MD, AGAF, FACP, is a double board-certified clinical gastroenterologist,  leading a team that treats all GI conditions. Dr. Buch sits on editorial boards for numerous professional journals and is a highly sought-after international presenter.

Dr. Buch has a passion for teaching. His style is case-based, practical, very interactive and evidence supported. Dr. Buch’s expertise has been shared with experienced clinicians and advanced-level students. He teaches at the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, the Frank H Netter School of Medicine/Quinnipiac University and the University of Connecticut APRN School.

 

Speaker Disclosures:
Financial: Dr. Peter S. Buch has employment relationships with the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, and the Frank H Netter, MD School of Medicine. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Peter S. Buch serves on the FDA and Patient Care Committees at the American College of Gastroenterology. He serves as an editor of peer-reviewed journals. He is a member of the International Association of Medical Science Educators, the AGA Academy of Educators, the American Gastroenterological Association (AGAF), the American College of Physicians (FACP), the Hartford County Medical Association, the American College of Gastroenterology (FACG), and the Connecticut State Medical Society.

 

Content Disclosure:

Dr. Buch references the use of antidepressants for Irritable Bowel Syndrome, and the controversial use of Fibrotest to evaluate patients with fatty liver disease who may have fibrosis of the liver. Dr. Buch indicates he wishes to present a fair and balanced approach to practitioners regarding such practices.

 

 


Additional Info

Access for Self-Study (Non-Interactive)

Access never expires for this product.


Questions?

Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info


Objectives

  1. Evaluate medical mimickers of GERD to make the right clinical diagnosis.
  2. Compare the clinical differences between PPIs.
  3. Discuss Vonoprazan as a PPI alternative.
  4. Plan to incorporate updates and tools to confidently manage patients with GERD, dyspepsia, and Barrett’s esophagus.

Outline

GERD
  • How to make the diagnosis of GERD
  • Factors that increase GERD
  • Unusual manifestations of GERD
  • PPI efficacy for unusual manifestations
  • Foods and meds that exacerbate GERD
  • Complications of GERD
Dyspepsia as a mimicker of GERD
  • Define dyspepsia/functional dyspepsia
  • How to distinguish dyspepsia/functional dyspepsia from GERD
Alarm “Signs” and GERD

Gastroparesis as a Mimicker of GERD
  • Etiologies and treatment of gastroparesis
Achalasia as a Mimicker of GERD
  • Treatment of achalasia
PPIs
  • Are there clinical differences among PPIs?
  • ”Tachyphylaxis”
  • PPI overuse
PPI Side Effects Discussion
  • Reality vs observational data
  • How to “de prescribe” PPIs
  • Reasons to continue PPIs
Vonoprazan
  • The new kid on the block
  • Benefits over PPIs
Barrett’s esophagus
  • Risk factors: Which women should be screened for Barrett’s
  • Cancer risk
  • Limitations of endoscopy
    • Accuracy of current guidelines to detect Ca
  • Do PPIs & NSAIDS prevent progression of Barrett’s to cancer
  • How to manage low grade dysplasia
  • Does Barrett’s ever disappear
  • What age should we stop Barret’s surveillance

Target Audience

  • NPs
  • APRNs
  • PAs
  • PharmDs
  • MDs
  • DOs

Reviews

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.

ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

PESI Mobile App

Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.

https://cdn.pesi23.com/images/android.png     https://cdn.pesi23.com/images/iphone.png

Please wait ...

Back to Top